Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics

Clin Pharmacol Ther. 2021 Sep;110(3):555-558. doi: 10.1002/cpt.2328. Epub 2021 Jul 13.

Authors

Kelsey J Cook^{1

2}, Benjamin Q Duong³, Nathan D Seligson^{1

2}, Pamela Arn², Vicky L Funanage³, Karen W Gripp^{3

4}, Susan M Kirwin³, Stephen T Lawless^{3

4}, Mary M Lee^{3

4}, Katherine M Robbins³, David West³, Kathryn V Blake²

Affiliations

¹ Department of Pharmacotherapy and Translational Research, The University of Florida College of Pharmacy, Jacksonville, Florida, USA.
² Precision Medicine Program, Nemours Children's Health, Jacksonville, Florida, USA.
³ Precision Medicine Program, Nemours Children's Health, Wilmington, Delaware, USA.
⁴ Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.

PMID: 34254671
DOI: 10.1002/cpt.2328

No abstract available

MeSH terms

Decision Support Systems, Clinical
Electronic Health Records
Genomics / methods*
Humans
Pharmacogenetics / methods*
Precision Medicine / methods